John Orwin, President & CEO, Director at Relypsa Inc, holds 77.54K shares in Atreca (Ticker: BCEL), holds 0.00 shares in Seagen (Ticker: SGEN), holds 22.38K shares in Travere Therapeutics (Ticker: TVTX). Most recently, John Orwin Bought ― shares of Atreca on Apr 17, 2024 for an estimated value of 0.01.